Cargando…
The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study
BACKGROUND AND AIMS: Current understanding of the risk of neoplastic progression in patients with Barrett's esophagus with indefinite dysplasia (BE-IND) stems from small retrospective and pathology registry studies. In this multicenter cohort study, we aimed to determine the incidence and preva...
Autores principales: | Phillips, Richard, Januszewicz, Wladyslaw, Pilonis, Nastazja D., O'Donovan, Maria, Sawas, Tarek, Katzka, David A., Fitzgerald, Rebecca C., di Pietro, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby Yearbook
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611297/ https://www.ncbi.nlm.nih.gov/pubmed/33548281 http://dx.doi.org/10.1016/j.gie.2021.01.042 |
Ejemplares similares
-
The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022) -
Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
por: Waterhouse, Dale J., et al.
Publicado: (2021) -
“Indefinite for Dysplasia” in Barrett's Esophagus: Inflammation and DNA Content Abnormality are Significant Predictors of Early Detection of Neoplasia
por: Choi, Won-Tak, et al.
Publicado: (2015) -
The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett’s esophagus
por: Vithayathil, Mathew, et al.
Publicado: (2023) -
Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia
por: Horvath, Bela, et al.
Publicado: (2016)